Volume 140, Issue 4, Pages (April 2011)

Slides:



Advertisements
Similar presentations
Thierry Delaunoit, Paul J. Limburg, Richard M. Goldberg, James F
Advertisements

Volume 146, Issue 7, Pages e3 (June 2014)
Volume 119, Issue 4, Pages (October 2000)
A Prospective, Multicenter, Population-Based Study of BRAF Mutational Analysis for Lynch Syndrome Screening  Xavier Bessa, Belen Ballesté, Montserrat.
Volume 146, Issue 4, Pages (April 2014)
Circulating MicroRNAs as Biomarkers of Colorectal Cancer: Results From a Genome- Wide Profiling and Validation Study  María Dolores Giráldez, Juan José.
Volume 136, Issue 2, Pages e1 (February 2009)
An Unusual Cause of Lower Gastrointestinal Bleeding
Volume 148, Issue 1, Pages (January 2015)
Christoph Lübbert, Babett Holler  Gastroenterology 
Volume 150, Issue 4, Pages (April 2016)
Volume 150, Issue 4, Pages (April 2016)
Volume 137, Issue 3, Pages (September 2009)
Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery  Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.
Nadir Arber, Bernard Levin  Gastroenterology 
Volume 139, Issue 6, Pages (December 2010)
When Should We Suspect Hereditary Colorectal Cancer Syndrome?
Volume 132, Issue 1, Pages (January 2007)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Proliferating Endothelial Cells and Leukocyte Infiltration as Prognostic Markers in Colorectal Cancer  Coen I.M. Baeten, Karolien Castermans, Harry F.P.
Volume 134, Issue 1, Pages (January 2008)
Volume 138, Issue 5, Pages e1 (May 2010)
Volume 119, Issue 4, Pages (October 2000)
Long-term Recurrence-free Survival After Standard Endoscopic Resection Versus Surgical Resection of Submucosal Invasive Colorectal Cancer: A Population-based.
Volume 147, Issue 3, Pages (September 2014)
Volume 146, Issue 7, Pages e3 (June 2014)
Volume 155, Issue 4, Pages (October 2018)
Covering the Cover Gastroenterology
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Volume 154, Issue 4, Pages e7 (March 2018)
Ajay Goel, Takeshi Nagasaka, Jennifer Spiegel, Richard Meyer, Warren E
Volume 133, Issue 6, Pages (December 2007)
Volume 123, Issue 5, Pages (November 2002)
Volume 136, Issue 1, Pages (January 2009)
Volume 153, Issue 6, Pages e8 (December 2017)
Not Your Ordinary Ulcer: A Cautionary Tale of an Uncommon Condition
Volume 134, Issue 7, Pages e1 (June 2008)
Patients With Celiac Disease and B-Cell Lymphoma Have a Better Prognosis Than Those With T-Cell Lymphoma  Thorvardur R. Halfdanarson, Alberto Rubio–Tapia,
Detection of BRAF V600E Mutation in Colorectal Cancer
Amir Shlomai, Ana Tobar, Ofer Benjaminov  Gastroenterology 
Kaplan-Maier survival curves of 10-year DFS (A and B) and OS (C and D) according to PS 0 and PS≥1 in patients treated with adjuvant chemotherapy after.
Covering the Cover Gastroenterology
Coffee and Colorectal Cancer: Grounds for Prevention?
Genetic Testing for Hereditary Colorectal Cancer: Challenges in Identifying, Counseling, and Managing High-Risk Patients  Elena M. Stoffel, Anu Chittenden 
Sharif B. Missiha, Mario Ostrowski, E. Jenny Heathcote 
Volume 136, Issue 5, Pages (May 2009)
Volume 136, Issue 7, Pages (June 2009)
Volume 133, Issue 2, Pages (August 2007)
Targeted Therapies for Hepatocellular Carcinoma
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Covering the Cover Gastroenterology
Caitlin C. Murphy, Kristin Wallace, Robert S. Sandler, John A. Baron 
Volume 137, Issue 5, Pages e3 (November 2009)
This Month in Gastroenterology
Mohamad H. Imam, Marina G. Silveira, Emmanouil Sinakos, Andrea A
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Adjuvant Surgery after Carboplatin and VP16 in Resectable Small Cell Lung Cancer  Giulia Veronesi, MD, Paolo Scanagatta, MD, Francesco Leo, MD, Tommaso.
Volume 156, Issue 4, Pages (March 2019)
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Esophageal Tumor After Radical Surgery for Gastric Cancer
Antoni Castells, Sergi Castellví–Bel, Francesc Balaguer 
Cancer Costs Projected to Reach at Least $158 Billion in 2020
Covering the Cover Gastroenterology
Volume 138, Issue 6, Pages (May 2010)
Volume 151, Issue 2, Pages (August 2016)
Volume 135, Issue 5, Pages (November 2008)
Thierry Delaunoit, Paul J. Limburg, Richard M. Goldberg, James F
Presentation transcript:

Volume 140, Issue 4, Pages 1174-1181 (April 2011) 5-Fluorouracil Adjuvant Chemotherapy Does Not Increase Survival in Patients With CpG Island Methylator Phenotype Colorectal Cancer  Rodrigo Jover, Thuy–Phuong Nguyen, Lucía Pérez–Carbonell, Pedro Zapater, Artemio Payá, Cristina Alenda, Estefanía Rojas, Joaquín Cubiella, Francesc Balaguer, Juan D. Morillas, Juan Clofent, Luis Bujanda, Josep M. Reñé, Xavier Bessa, Rosa M. Xicola, David Nicolás–Pérez, Antoni Castells, Montserrat Andreu, Xavier Llor, C. Richard Boland, Ajay Goel  Gastroenterology  Volume 140, Issue 4, Pages 1174-1181 (April 2011) DOI: 10.1053/j.gastro.2010.12.035 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Kaplan–Meier survival curves depicting the effect of CIMP status on DFS in (A) the entire series of CRCs and (B) patients with TNM stage II and III CRCs. Vertical tick marks indicate censored events. Gastroenterology 2011 140, 1174-1181DOI: (10.1053/j.gastro.2010.12.035) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 Kaplan–Meier survival curves showing the effect of CIMP status on survival according to 5-FU–based chemotherapy treatment. (A) In patients with CIMP-negative tumors, adjuvant chemotherapy clearly provides a survival benefit with a higher probability of DFS (log-rank 0.00001). (B) In patients with CIMP-positive tumors, the use of 5-FU–based adjuvant chemotherapy does not improve DFS (log-rank 0.7). Vertical tick marks indicate censored events. Gastroenterology 2011 140, 1174-1181DOI: (10.1053/j.gastro.2010.12.035) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 Kaplan–Meier survival curves indicating the effect of chemotherapy on survival according to CIMP status. (A) In patients who received 5-FU–based adjuvant chemotherapy, the existence of a CIMP-positive tumor confers a worse prognosis, with lower DFS (log-rank 0.02). (B) In contrast, in patients who did not receive adjuvant chemotherapy, the situation reverses, and those with CIMP-positive tumors had a better prognosis (log-rank 0.04). Vertical tick marks indicate censored events. Gastroenterology 2011 140, 1174-1181DOI: (10.1053/j.gastro.2010.12.035) Copyright © 2011 AGA Institute Terms and Conditions